Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories

被引:187
作者
Gould, PA [1 ]
Krahn, AD [1 ]
机构
[1] Univ Western Ontario, Div Cardiol, Dept Med, London, ON, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 16期
关键词
D O I
10.1001/jama.295.16.1907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Recent implantable cardioverter-defibrillator (ICD) advisories and recalls have caused management dilemmas for physicians, particularly because there are no specific guidelines or data on outcomes from current management strategies. The risk of ICD generator replacement has not been assessed in this population. Objective To determine the complication rate associated with ICD generator replacement for the current ICD advisories. Design and Setting Seventeen ICD implanting centers in Canada were surveyed to assess complication rates as a result of generator replacements because of ICD advisories from October 2004 to October 2005. Main Outcome Measure Complications associated with elective ICD generator replacement for current device advisories. Results At the 17 surveyed centers, 2915 patients had recall devices, including 533 (18.3%) who had advisory ICDs replaced a mean (SD) of 26.5 (11.5) months after their initial implant. Of these patients, 66% had a secondary prevention ICD, and 45% had received a previous appropriate shock. During a mean (SD) of 2.7 (2.8) months' follow-up after ICD generator replacement, complications occurred in 43 patients (8.1%). Major complications attributable to advisory device replacement requiring reoperation occurred in 31 patients (5.8%), with death in 2 patients after extraction for pocket infection. Minor complications occurred in 12 patients (2.3%). There were 3 (0.1%) advisory-related device malfunctions reported, without clinical consequences. Conclusions ICD generator replacement in patients with advisory devices is associated with a substantial rate of complications, including death. These complications need to be considered in the development of guidelines determining the appropriate treatment of patients with advisory devices.
引用
收藏
页码:1907 / 1911
页数:5
相关论文
共 23 条
[1]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[2]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[3]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[4]   Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996 [J].
Byrd, CL ;
Wilkoff, BL ;
Love, CJ ;
Sellers, TD ;
Turk, KT ;
Reeves, R ;
Young, R ;
Crevey, B ;
Kutalek, SP ;
Freedman, R ;
Friedman, R ;
Trantham, J ;
Watts, M ;
Schutzman, J ;
Oren, J ;
Wilson, J ;
Gold, F ;
Fearnot, NE ;
Van Zandt, HJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (09) :1348-1357
[5]   Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone [J].
Connolly, SJ ;
Gent, M ;
Roberts, RS ;
Dorian, P ;
Roy, D ;
Sheldon, RS ;
Mitchell, LB ;
Green, MS ;
Klein, GJ ;
O'Brien, B .
CIRCULATION, 2000, 101 (11) :1297-1302
[6]   Management of intracardiac device recalls: A consensus conference [J].
Goldman, BS ;
Newman, D ;
Fraser, J ;
Irwin, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (01) :7-17
[7]   Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy [J].
Gornick, CC ;
Hauser, RG ;
Almquist, AK ;
Maron, BJ .
HEART RHYTHM, 2005, 2 (07) :681-683
[8]  
Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09
[9]  
Higgins SL, 1999, AM J CARDIOL, V83, p79D
[10]   Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction [J].
Hohnloser, SH ;
Kuck, KH ;
Dorian, P ;
Roberts, RS ;
Hampton, JR ;
Hatala, R ;
Fain, E ;
Gent, M ;
Connolly, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2481-2488